FibroGen, Inc. Alternatives & Competitors
12 companies similar to FibroGen, Inc. — Committed to being a place where our people and science thrive.
Companies similar to FibroGen, Inc.
Curis
Working relentlessly to develop innovative and differentiated therapeutics that improve th...
Farcast Biosciences
24,000 human tumors and counting - building the most precise functional precision tumor mi...
Arcus Biosciences
Biopharmaceutical company developing differentiated molecules and combination therapies fo...
Xencor
Proteins by Design
Rival Readout
Competing with FibroGen, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Elixirgen Therapeutics, Inc.
Reimagine the Power of RNA
Biocon
Transforming Healthcare. Transforming Lives.
FogPharma
Until everything is druggable.
GamaMabs Pharma
Advancing the future of immuno-oncology with innovative monoclonal antibody treatments
ImmunGene
Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...
Agomab
Unlocking Disease Modification in Fibro-Inflammation
IOME BIO
Harnessing unique, proprietary microbiome insights to unlock the efficacy of immuno-oncolo...
A&G Pharmaceutical, Inc.
Pioneering the future of cancer treatment and diagnostics through innovative monoclonal an...
About FibroGen, Inc.
FibroGen, Inc., founded in 1993, is a United States-based company operating in the biopharma and biotechnology sectors. The company is dedicated to pioneering first-in-class therapeutics targeting significant unmet medical needs globally, with a focus on areas such as anemia, fibrotic disease, and cancer. Leveraging th...
R&D Pipeline Management, Clinical Trials Execution, Drug Development, Scientific Research and Innovation
Healthcare Providers, Medical Researchers, Pharmaceutical Investors, Patients with Prostate Cancer, Patients with Anemia
Connective Tissue Growth Factor, Hypoxia-Inducible Factor Biology, Monoclonal Antibodies, HIF-PH Inhibitors, Anemia Treatment, Fibrotic Disease, Cancer Therapeutics, Pancreatic Cancer Treatment, Duchenne Muscular Dystrophy, Immuno-Oncology, Autoimmune Disorders, Biotechnology Research, Drug Development, Clinical Development
B2B, B2C
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around FibroGen, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at FibroGen, Inc. on 2 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.